EMERALD HOLDING INC (EEX)

US29103W1045 - Common Stock

5.65  -0.21 (-3.58%)

After market: 5.65 0 (0%)

Fundamental Rating

3

Taking everything into account, EEX scores 3 out of 10 in our fundamental rating. EEX was compared to 96 industry peers in the Media industry. Both the profitability and financial health of EEX have multiple concerns. While showing a medium growth rate, EEX is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year EEX has reported negative net income.
EEX had a positive operating cash flow in the past year.
In the past 5 years EEX reported 4 times negative net income.
Of the past 5 years EEX 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of EEX (-4.76%) is worse than 66.32% of its industry peers.
Looking at the Return On Equity, with a value of -12.41%, EEX is doing worse than 63.16% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.54%, EEX is doing good in the industry, outperforming 65.26% of the companies in the same industry.
Industry RankSector Rank
ROA -4.76%
ROE -12.41%
ROIC 4.54%
ROA(3y)-4.19%
ROA(5y)-15.51%
ROE(3y)-13.77%
ROE(5y)-42.74%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EEX's Operating Margin of 11.81% is fine compared to the rest of the industry. EEX outperforms 73.68% of its industry peers.
EEX's Operating Margin has declined in the last couple of years.
EEX's Gross Margin of 64.05% is fine compared to the rest of the industry. EEX outperforms 77.89% of its industry peers.
In the last couple of years the Gross Margin of EEX has declined.
Industry RankSector Rank
OM 11.81%
PM (TTM) N/A
GM 64.05%
OM growth 3Y-3.23%
OM growth 5Y-16.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.92%
GM growth 5Y-1.82%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EEX is destroying value.
EEX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EEX has been reduced compared to 5 years ago.
The debt/assets ratio for EEX is higher compared to a year ago.

2.2 Solvency

EEX has an Altman-Z score of 0.07. This is a bad value and indicates that EEX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EEX (0.07) is worse than 77.89% of its industry peers.
The Debt to FCF ratio of EEX is 13.99, which is on the high side as it means it would take EEX, 13.99 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 13.99, EEX perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
A Debt/Equity ratio of 0.99 indicates that EEX is somewhat dependend on debt financing.
EEX has a Debt to Equity ratio of 0.99. This is in the lower half of the industry: EEX underperforms 61.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 13.99
Altman-Z 0.07
ROIC/WACC0.51
WACC8.93%

2.3 Liquidity

EEX has a Current Ratio of 1.35. This is a normal value and indicates that EEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.35, EEX is doing worse than 63.16% of the companies in the same industry.
EEX has a Quick Ratio of 1.35. This is a normal value and indicates that EEX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of EEX (1.35) is worse than 61.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35

5

3. Growth

3.1 Past

EEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -297.50%.
The Revenue has grown by 17.46% in the past year. This is quite good.
The Revenue has been growing slightly by 0.11% on average over the past years.
EPS 1Y (TTM)-297.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-757.14%
Revenue 1Y (TTM)17.46%
Revenue growth 3Y44.3%
Revenue growth 5Y0.11%
Revenue growth Q2Q8.44%

3.2 Future

Based on estimates for the next years, EEX will show a very strong growth in Earnings Per Share. The EPS will grow by 43.36% on average per year.
EEX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.90% yearly.
EPS Next Y41.83%
EPS Next 2Y36.36%
EPS Next 3Y43.36%
EPS Next 5YN/A
Revenue Next Year7.22%
Revenue Next 2Y8.73%
Revenue Next 3Y25.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EEX indicates a rather cheap valuation: EEX is cheaper than 84.21% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EEX indicates a somewhat cheap valuation: EEX is cheaper than 66.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.37
EV/EBITDA 6.3

4.3 Compensation for Growth

EEX's earnings are expected to grow with 43.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.36%
EPS Next 3Y43.36%

0

5. Dividend

5.1 Amount

No dividends for EEX!.
Industry RankSector Rank
Dividend Yield N/A

EMERALD HOLDING INC

NYSE:EEX (4/29/2024, 7:04:00 PM)

After market: 5.65 0 (0%)

5.65

-0.21 (-3.58%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap356.12M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.76%
ROE -12.41%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.81%
PM (TTM) N/A
GM 64.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-297.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y41.83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.46%
Revenue growth 3Y44.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y